A detailed history of Invesco Ltd. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Invesco Ltd. holds 1,005,108 shares of BCRX stock, worth $7.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,005,108
Previous 101,923 886.14%
Holding current value
$7.61 Million
Previous $629,000 1114.31%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.41 - $8.69 $5.79 Million - $7.85 Million
903,185 Added 886.14%
1,005,108 $7.64 Million
Q2 2024

Aug 13, 2024

BUY
$4.13 - $6.79 $10,374 - $17,056
2,512 Added 2.53%
101,923 $629,000
Q1 2024

May 14, 2024

BUY
$4.89 - $7.65 $9,647 - $15,093
1,973 Added 2.02%
99,411 $505,000
Q4 2023

Feb 12, 2024

SELL
$4.98 - $6.77 $12,435 - $16,904
-2,497 Reduced 2.5%
97,438 $583,000
Q3 2023

Nov 13, 2023

SELL
$6.71 - $7.92 $1,966 - $2,320
-293 Reduced 0.29%
99,935 $707,000
Q2 2023

Aug 11, 2023

BUY
$6.96 - $8.81 $23,162 - $29,319
3,328 Added 3.43%
100,228 $705,000
Q1 2023

May 12, 2023

SELL
$7.94 - $11.84 $2.07 Million - $3.08 Million
-260,155 Reduced 72.86%
96,900 $808,000
Q4 2022

Feb 13, 2023

SELL
$10.5 - $14.2 $58,243 - $78,767
-5,547 Reduced 1.53%
357,055 $4.1 Million
Q3 2022

Nov 14, 2022

BUY
$10.79 - $14.81 $877,507 - $1.2 Million
81,326 Added 28.91%
362,602 $4.57 Million
Q2 2022

Aug 15, 2022

BUY
$7.89 - $17.88 $457,588 - $1.04 Million
57,996 Added 25.97%
281,276 $2.98 Million
Q1 2022

May 16, 2022

BUY
$11.56 - $19.76 $217,963 - $372,574
18,855 Added 9.22%
223,280 $3.63 Million
Q4 2021

Feb 14, 2022

SELL
$11.18 - $15.46 $44,038 - $60,896
-3,939 Reduced 1.89%
204,425 $2.83 Million
Q3 2021

Nov 15, 2021

SELL
$14.21 - $17.65 $7.73 Million - $9.6 Million
-543,748 Reduced 72.3%
208,364 $3 Million
Q2 2021

Aug 17, 2021

SELL
$9.5 - $17.24 $6.48 Million - $11.8 Million
-681,726 Reduced 47.55%
752,112 $11.9 Million
Q1 2021

May 17, 2021

BUY
$7.37 - $13.61 $10.3 Million - $19 Million
1,396,756 Added 3766.67%
1,433,838 $14.6 Million
Q4 2020

Feb 16, 2021

BUY
$3.37 - $8.61 $84,883 - $216,868
25,188 Added 211.77%
37,082 $276,000
Q3 2020

Nov 16, 2020

BUY
$3.43 - $5.53 $1,478 - $2,383
431 Added 3.76%
11,894 $41,000
Q2 2020

Aug 14, 2020

BUY
$1.9 - $5.61 $21,779 - $64,307
11,463 New
11,463 $55,000
Q3 2019

Nov 14, 2019

SELL
$2.5 - $3.73 $3.62 Million - $5.4 Million
-1,446,732 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$2.91 - $9.15 $1.64 Million - $5.16 Million
563,822 Added 63.86%
1,446,732 $5.48 Million
Q1 2019

May 15, 2019

SELL
$7.38 - $9.72 $898,994 - $1.18 Million
-121,815 Reduced 12.12%
882,910 $7.19 Million
Q4 2018

Feb 14, 2019

BUY
$6.51 - $9.6 $6.54 Million - $9.65 Million
1,004,725 New
1,004,725 $8.11 Million

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.